|
1
|
Tella SH and Gallagher JC: Prevention and
treatment of postmenopausal osteoporosis. J Steroid Biochem Mol
Biol. 142:155–170. 2015. View Article : Google Scholar
|
|
2
|
Hiligsmann M, Evers SM, Ben Sedrine W,
Kanis JA, Ramaekers B, Reginster JY, Silverman S, Wyers CE and
Boonen A: A systematic review of cost-effectiveness analyses of
drugs for postmenopausal osteoporosis. Pharmacoeconomics.
33:205–224. 2014. View Article : Google Scholar
|
|
3
|
Schwarz P, Jorgensen NR and Abrahamsen B:
Status of drug development for the prevention and treatment of
osteoporosis. Expert Opin Drug Discov. 9:245–253. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ishikawa K, Nagai T, Sakamoto K, Ohara K,
Eguro T, Ito H, Toyoshima Y, Kokaze A, Toyone T and Inagaki K: High
bone turnover elevates the risk of denosumab-induced hypocalcemia
in women with postmenopausal osteoporosis. Ther Clin Risk Manag.
12:1831–1840. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lo Russo L, Lo Muzio L, Buccelli C and Di
Lorenzo P: Bisphosphonate-related osteonecrosis of the jaws: Legal
liability from the perspective of the prescribing physician. J Bone
Miner Metab. 31:601–603. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mukwaya E, Xu F, Wong MS and Zhang Y:
Chinese herbal medicine for bone health. Pharm Biol. 52:1223–1228.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chopra B, Kumar A and Lal K: Psoralea
corylifolia L. (Buguchi)-Folklore to modern evidence: Review.
Fitoterapia. 90:44–56. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang YF, Liu YN, Xiong W, Yan DM, Zhu Y,
Gao XM, Xu YT and Qi AD: A UPLC-MS/MS method for in vivo and in
vitro pharmacokinetic studies of psoralenoside, isopsoralenoside,
psoralen and isopsoralen from Psoralea corylifolia extract. J
Ethnopharmacol. 151:609–617. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang J, Li SF, Wang T, Sun CH, Wang L,
Huang MJ, Chen J, Zheng SW, Wang N, Zhang YJ and Chen TY:
Isopsoralen-mediated suppression of bone marrow adiposity and
attenuation of the adipogenic commitment of bone marrow-derived
mesenchymal stem cells. Int J Mol Med. 39:527–538. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yuan X, Bi Y, Yan Z, Pu W, Li Y and Zhou
K: Psoralen and isopsoralen ameliorate sex hormone
deficiency-induced osteoporosis in female and male mice. Biomed Res
Int. 2016:68694522016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yeh LC, Adamo ML, Kitten AM, Olson MS and
Lee JC: Osteogenic protein-1-mediated insulin-like growth factor
gene expression in primary cultures of rat osteoblastic cells.
Endocrinology. 137:1921–1931. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Neve A, Corrado A and Cantatore FP:
Osteoblast physiology in normal and pathological conditions. Cell
Tissue Res. 343:289–302. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Repp F, Kollmannsberger P, Roschger A,
Berzlanovich A, Gruber GM, Roschger P, Wagermaier W and Weinkamer
R: Coalignment of osteocyte canaliculi and collagen fibers in human
osteonal bone. J Struct Biol. 199:177–186. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liu JC, Lengner CJ, Gaur T, Lou Y, Hussain
S, Jones MD, Borodic B, Colby JL, Steinman HA, van Wijnen AJ, et
al: Runx2 protein expression utilizes the Runx2 P1 promoter to
establish osteoprogenitor cell number for normal bone formation. J
Biol Chem. 286:30057–30070. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hoemann CD, El-Gabalawy H and McKee MD: In
vitro osteogenesis assays: Influence of the primary cell source on
alkaline phosphatase activity and mineralization. Pathol Biol
(Paris). 57:318–323. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li XM, Yang Q, Li XB, Cheng Q, Zhang K and
Han J: Estrogen-like neuroprotection of isopsoralen against spinal
cord injury through estrogen receptor ERα. Metab Brain Dis.
32:259–265. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang Y, Lu Y, Li Z, Zhou Y, Gu Y, Pang X,
Wu J, Gobin R and Yu J: Oestrogen receptor alpha regulates the
odonto/osteogenic differentiation of stem cells from apical papilla
via ERK and JNK MAPK pathways. Cell Prolif. 51:e124852018.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Srnec R, Divin R, Skoric M, Snasil R,
Krbec M and Necas A: Use of the Peptigel with Nanofibres in the
bone defects healing. Acta Chir Orthop Traumatol Cech. 85:359–365.
2018.(In Czech). PubMed/NCBI
|
|
20
|
Zhang K, Wang M, Li Y, Li C, Tang S, Qu X,
Feng N and Wu Y: The PERK-EIF2α-ATF4 signaling branch regulates
osteoblast differentiation and proliferation by PTH. Am J Physiol
Endocrinol Metab. 2019.(Epub ahead of print). View Article : Google Scholar :
|
|
21
|
Xi G, Wai C, Rosen CJ and Clemmons DR: A
peptide containing the receptor binding site of insulin-like growth
factor binding protein-2 enhances bone mass in ovariectomized rats.
Bone Res. 6:232018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Halling Linder C, Ek-Rylander B, Krumpel
M, Norgård M, Narisawa S, Millán JL, Andersson G and Magnusson P:
Bone alkaline phosphatase and tartrate-resistant acid phosphatase:
Potential co-regulators of bone mineralization. Calcif Tissue Int.
101:92–101. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bruderer M, Richards RG, Alini M, Stoddart
MJ and Platz D: Role and regulation of runx2 in osteogenesis. Eur
Cell Mater. 28:269–286. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Komori T: Runx2, an inducer of osteoblast
and chondrocyte differentiation. Histochem Cell Biol. 149:313–323.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Rosen V: BMP2 signaling in bone
development and repair. Cytokine Growth Factor Rev. 20:475–480.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jang WG, Kim EJ, Kim DK, Ryoo HM, Lee KB,
Kim SH, Choi HS and Koh JT: BMP2 protein regulates osteocalcin
expression via Runx2- mediated Atf6 gene transcription. J Biol
Chem. 287:905–915. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Stevens ML, Chaturvedi P, Rankin SA,
Macdonald M, Jagannathan S, Yukawa M, Barski A and Zorn AM: Genomic
integration of Wnt/β-catenin and BMP/Smad1 signaling coordinates
foregut and hindgut transcriptional programs. Development.
144:1283–1295. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang R, Oyajobi BO, Harris SE, Chen D,
Tsao C, Deng HW and Zhao M: Wnt/β-catenin signaling activates bone
morphogenetic protein 2 expression in osteoblasts. Bone.
52:145–156. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Gifre L, Vidal J, Carrasco JL, Filella X,
Ruiz-Gaspà S, Muxi A, Portell E, Monegal A, Guañabens N and Peris
P: Effect of recent spinal cord injury on Wnt signaling antagonists
(sclerostin and Dkk-1) and their relationship with bone loss. A
12-month prospective study. J Bone Miner Res. 30:1014–1021. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Armstrong VJ, Muzylak M, Sunters A, Zaman
G, Saxon LK, Price JS and Lanyon LE: Wnt/beta-catenin signaling is
a component of osteoblastic bone cell early responses to
load-bearing and requires estrogen receptor alpha. J Biol Chem.
282:20715–20727. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Gao Y, Huang E, Zhang H, Wang J, Wu N,
Chen X, Wang N, Wen S, Nan G, Deng F, et al: Crosstalk between
Wnt/β-catenin and estrogen receptor signaling synergistically
promotes osteogenic differentiation of mesenchymal progenitor
cells. PLoS One. 8:e824362013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Bord S, Horner A, Beavan S and Compston J:
Estrogen receptors alpha and beta are differentially expressed in
developing human bone. J Clin Endocrinol Metab. 86:2309–2314. 2014.
View Article : Google Scholar
|
|
33
|
Khalid AB and Krum SA: Estrogen receptors
alpha and beta in bone. Bone. 87:130–135. 2017. View Article : Google Scholar
|
|
34
|
Galea GL, Meakin LB, Sugiyama T, Zebda N,
Sunters A, Taipaleenmaki H, Stein GS, van Wijnen AJ, Lanyon LE and
Price JS: Estrogen receptor α mediates proliferation of
osteoblastic cells stimulated by estrogen and mechanical strain,
but their acute down-regulation of the Wnt antagonist Sost is
mediated by estrogen receptor β. J Biol Chem. 288:9035–9048. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kondoh S, Inoue K, Igarashi K, Sugizaki H,
Shirode-Fukuda Y, Inoue E, Yu T, Takeuchi JK, Kanno J, Bonewald LF
and Imai Y: Estrogen receptor α in osteocytes regulates trabecular
bone formation in female mice. Bone. 60:68–77. 2015. View Article : Google Scholar
|
|
36
|
Windahl SH, Börjesson AE, Farman HH,
Engdahl C, Movérare-Skrtic S, Sjögren K, Lagerquist MK, Kindblom
JM, Koskela A, Tuukkanen J, et al: Estrogen receptor-α in
osteocytes is important for trabecular bone formation in male mice.
Proc Natl Acad Sci USA. 110:2294–2299. 2013. View Article : Google Scholar : PubMed/NCBI
|
